Generics

Filter

Current filters:

None

Popular Filters

1 to 25 of 1186 results

Russia tightens procedure for accelerated registration of drugs

27-11-2014

Only the first three generics, along with generics intended for minors, as well as orphan drugs, will…

GenericsRegulationRussia

AbbVie acquires API facility in Singapore; Amgen completes new unit

AbbVie acquires API facility in Singapore; Amgen completes new unit

26-11-2014

US pharma major AbbVie has acquired a small-molecule active pharmaceutical ingredient (API) manufacturing…

AbbVieAmgenBiotechnologyGenericsProductionSingapore

Mylan confirms first-to-file patent challenge relating to Brevibloc

25-11-2014

US generic drugmaker Mylan today confirmed that it and several subsidiaries have been sued by US drugmaker…

Baxter InternationalBreviblocCardio-vascularGenericsLegalMylanPatentsRegulationUSA

Supernus sues Zydus for infringement of Trokendi XR patents

25-11-2014

US drugmaker Supernus Pharmaceuticals has sued generic drug makers Zydus Pharmaceuticals (USA) and Indian…

GenericsLegalNeurologicalPatentsSupernus PharmaceuticalsUSAZydus Cadila

GPhA slams mischaracterized facts about generic drug pricing

GPhA slams mischaracterized facts about generic drug pricing

24-11-2014

Commenting on recent evaluations of generic drug prices, Ralph Neas, president and chief executive of…

GenericsLegalPoliticsPricingUSA

China pharma excipients market to reach $8.9 billion in 2017

China pharma excipients market to reach $8.9 billion in 2017

24-11-2014

Currently, pharmaceutical excipients account for about 2%-3% of China's total output value of pharmaceutical…

ChinaGenericsMarkets & MarketingProduction

Beximco Pharma receives GMP approval from Health Canada

Beximco Pharma receives GMP approval from Health Canada

24-11-2014

Bangladeshi drugmaker Beximco Pharma has received Good Manufacturing Practices approval from Health Canada,…

BangladeshBeximco PharmaceuticalsCanadaGenericsProductionRegulation

Cipla links with SII for affordable pediatric vaccines in Europe

20-11-2014

The European subsidiary of Indian drugmaker Cipla has entered a distribution agreement with Serum Institute…

CiplaEuropeGenericsMarkets & MarketingSerum Institute of IndiaVaccines

Opportunity to promote good antibiotics prescription practices, says EGA

19-11-2014

The European Generic medicines Association (EGA) used the platform of European Antibiotic Awareness Day…

Antibiotics and Infectious diseasesEuropeGenericsMarkets & MarketingPricing

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

17-11-2014

The Competition Commission has asked Indian generics company Sun Pharmaceutical Industries, which acquired…

GenericsIndiaMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceutical

Good results from Stada Arz, despite challenging conditions

13-11-2014

German drugmaker Stada Arzneimittel has posted financial results for the first nine months of 2014, showing…

Eastern EuropeFinancialGenericsRussiaSTADA Arzneimittel

India takes action on spurious and sub-standard drugs

India takes action on spurious and sub-standard drugs

10-11-2014

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals…

GenericsIndiaMarkets & MarketingPharmaceuticalPoliticsRegulation

Advent and Avista acquire UCB’s generics subsidiary Kremers Urban

Advent and Avista acquire UCB’s generics subsidiary Kremers Urban

07-11-2014

Global private equity investors Advent International and Avista Capital Partners have signed an agreement…

BelgiumGenericsKremers Urban PharmaceuticalsMergers & AcquisitionsUCB

Actavis third-qtr sales rocket, but loss posted

Actavis third-qtr sales rocket, but loss posted

05-11-2014

Ireland-headquartered generics drug major Actavis today reported net revenue leapt 83% to $3.7 billion…

ActavisFinancialGenerics

EGA and EBG see EMA latest biosimilars guidance as “important step forward”

EGA and EBG see EMA latest biosimilars guidance as “important step forward”

04-11-2014

The European Generic medicines Association (EGA) and the European Biosimilars Group (EBG), a sector group…

BiosimilarsEuropeGenericsRegulation

New analysis of potential savings from Biosimilars in USA

New analysis of potential savings from Biosimilars in USA

04-11-2014

Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such…

Anti-Arthritics/RheumaticsBiosimilarsFinancialGenericsOncologyRegulationSandozUSA

Mylan third-qtr beats expectations

Mylan third-qtr beats expectations

31-10-2014

US generics drugmaker Mylan reported third-quarter 2014 financial results that beat analysts’ consensus…

FinancialGenericsMylan

Mylan debuts generic Viramune XR in USA

Mylan debuts generic Viramune XR in USA

31-10-2014

US generic drugmaker Mylan said yesterday that it has launched its nevirapine extended-release tablets,…

Anti-viralsBoehringer IngelheimGenericsMarkets & MarketingMylanUSAViramune

Canadian generics group in deal for C$560 million savings over three years

Canadian generics group in deal for C$560 million savings over three years

30-10-2014

Atlantic Canadians will save an estimated C$560 million ($500 million) through an unprecedented three-year…

CanadaGenericsPricing

Dr Reddy’s reports higher sales but downturn in pretax profit

Dr Reddy’s reports higher sales but downturn in pretax profit

29-10-2014

Indian generics drugmaker Dr Reddy’s Laboratories today reported its unaudited consolidated financial…

Dr Reddy's LaboratoriesFinancialGenerics

1 to 25 of 1186 results

Parexel

Parexel

Back to top